{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:35:41Z","timestamp":1790012141976,"version":"4.0.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41401-026-01872-z","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:33:28Z","timestamp":1783316008000},"page":"2777-2790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RNA m6A methylation writers in autoimmune diseases: structure, function, and therapeutic opportunities"],"prefix":"10.1038","volume":"47","author":[{"given":"Xue-feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-na","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-tai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1872_CR1","doi-asserted-by":"publisher","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","volume":"46","author":"P Boccaletto","year":"2018","unstructured":"Boccaletto P, Machnicka MA, Purta E, Piatkowski P, Baginski B, Wirecki TK, et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018;46:D303\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1872_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187\u2013200.","journal-title":"Cell"},{"key":"1872_CR3","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.7150\/thno.99019","volume":"14","author":"FT Bu","year":"2024","unstructured":"Bu FT, Wang HY, Xu C, Song KL, Dai Z, Wang LT, et al. The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases. Theranostics. 2024;14:4683\u2013700.","journal-title":"Theranostics"},{"key":"1872_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol C ell. 2019;74:640\u201350.","journal-title":"Mol C ell"},{"key":"1872_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63:306\u201317.","journal-title":"Mol Cell"},{"key":"1872_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.it.2021.10.002","volume":"42","author":"R Bechara","year":"2021","unstructured":"Bechara R, Gaffen SL. \u2018m6A\u2019 stands for \u2018autoimmunity\u2019: reading, writing, and erasing RNA modifications during inflammation. Trends Immunol. 2021;42:1073\u20136.","journal-title":"Trends Immunol"},{"key":"1872_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898.","journal-title":"Nat Commun"},{"key":"1872_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534:575\u20138.","journal-title":"Nature"},{"key":"1872_CR9","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, Tisn\u00e9 C. A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49:7239\u201355.","journal-title":"Nucleic Acids Res"},{"key":"1872_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02089-6","volume":"23","author":"D Chen","year":"2024","unstructured":"Chen D, Gu X, Nurzat Y, Xu L, Li X, Wu L, et al. Writers, readers, and erasers RNA modifications and drug resistance in cancer. Mol Cancer. 2024;23:178.","journal-title":"Mol Cancer"},{"key":"1872_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41596-023-00937-1","volume":"19","author":"W Shen","year":"2024","unstructured":"Shen W, Sun H, Liu C, Yi Y, Hou Y, Xiao Y, et al. GLORI for absolute quantification of transcriptome-wide m6A at single-base resolution. Nat Protoc. 2024;19:1252\u201387.","journal-title":"Nat Protoc"},{"key":"1872_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41589-019-0327-1","volume":"15","author":"XM Liu","year":"2019","unstructured":"Liu XM, Zhou J, Mao Y, Ji Q, Qian SB. Programmable RNA N(6)-methyladenosine editing by CRISPR-Cas9 conjugates. Nat Chem Biol. 2019;15:865\u201371.","journal-title":"Nat Chem Biol"},{"key":"1872_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymeth.2022.03.006","volume":"203","author":"X Sun","year":"2022","unstructured":"Sun X, Wang DO, Wang J. Targeted manipulation of m(6)A RNA modification through CRISPR-Cas-based strategies. Methods. 2022;203:56\u201361.","journal-title":"Methods"},{"key":"1872_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501408","volume":"12","author":"T Huang","year":"2025","unstructured":"Huang T, Chen S, Ding K, Yuan L, Lv W, Chen K, et al. METTL3\/ALKBH5-mediated N6-methyladenosine modification drives macrophage M1 polarization via the SLC15A3-TASL-IRF5 signaling axis in psoriasis. Adv Sci (Weinh). 2025;12:e01408.","journal-title":"Adv Sci (Weinh)"},{"key":"1872_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112684","volume":"42","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Wang S, Tian Y, Lv W, Sheng H, Zhan M, et al. METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate \u03b3\u03b4 T1 and \u03b3\u03b4 T17 cells. Cell Rep. 2023;42:112684.","journal-title":"Cell Rep"},{"key":"1872_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp5332","volume":"10","author":"L Cui","year":"2024","unstructured":"Cui L, Wu Y, Chen Z, Li B, Cai J, Chang Z, et al. N(6)-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis. Sci Adv. 2024;10:eadp5332.","journal-title":"Sci Adv"},{"key":"1872_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00403-024-03097-8","volume":"316","author":"X Du","year":"2024","unstructured":"Du X, Shi L, Wang B, Zhang G. WTAP mediated m6A-modified circ_0056856 contributes to the proliferation, migration, and invasion of IL-22-stimulated human keratinocyte by miR-197-3p\/CDK1 axis. Arch Dermatol Res. 2024;316:208.","journal-title":"Arch Dermatol Res"},{"key":"1872_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41422-022-00725-8","volume":"32","author":"S Su","year":"2022","unstructured":"Su S, Li S, Deng T, Gao M, Yin Y, Wu B, et al. Cryo-EM structures of human m6A writer complexes. Cell Res. 2022;32:982\u201394.","journal-title":"Cell Res"},{"key":"1872_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N6-adenosine methylation by the METTL3\u2013METTL14 complex. Nature. 2016;534:575\u20138.","journal-title":"Nature"},{"key":"1872_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92537","volume":"12","author":"I Corbeski","year":"2024","unstructured":"Corbeski I, Vargas-Rosales PA, Bedi RK, Deng J, Coelho D, Braud E, et al. The catalytic mechanism of the RNA methyltransferase METTL3. Elife. 2024;12:RP92537.","journal-title":"Elife"},{"key":"1872_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Sch\u00f6ller","year":"2018","unstructured":"Sch\u00f6ller E, Weichmann F, Treiber T, Ringle S, Treiber N, Flatley A, et al. Interactions, localization, and phosphorylation of the m6A generating METTL3-METTL14-WTAP complex. Rna. 2018;24:499\u2013512.","journal-title":"Rna"},{"key":"1872_CR22","doi-asserted-by":"publisher","unstructured":"Qi S, Kumar A, Chen S, Zhou S, Parihar M, Villalobos C, et al. Structure of METTL3-METTL14 with an m6A nucleotide reveals insights into m6A conversion and sensing. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-3150186.","DOI":"10.21203\/rs.3.rs-3150186"},{"key":"1872_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. M(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537:369\u201373.","journal-title":"Nature"},{"key":"1872_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1101\/gad.309146.117","volume":"32","author":"P Knuckles","year":"2018","unstructured":"Knuckles P, Lence L, Haussmann IU, Jacob D, Kreim N, Carl SH, et al. Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d. Genes Dev. 2018;32:415\u201329.","journal-title":"Genes Dev"},{"key":"1872_CR25","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/febs.13614","volume":"283","author":"A Maity","year":"2016","unstructured":"Maity A, Das B. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. FEBS J. 2016;283:1607\u201330.","journal-title":"FEBS J."},{"key":"1872_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tig.2019.10.011","volume":"36","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. The biogenesis and precise control of RNA m6A methylation. Trends Genet. 2020;36:44\u201352.","journal-title":"Trends Genet"},{"key":"1872_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177932","volume":"134","author":"Y Ge","year":"2024","unstructured":"Ge Y, Chen R, Ling T, Liu B, Huang J, Cheng Y, et al. Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models. J Clin Invest. 2024;134:e177932.","journal-title":"J Clin Invest"},{"key":"1872_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23892-5","volume":"12","author":"P Bawankar","year":"2021","unstructured":"Bawankar P, Lence T, Paolantoni C, Haussmann IU, Kazlauskiene M, Jacob D, et al. Hakai is required for stabilization of core components of the m6A mRNA methylation machinery. Nat Commun. 2021;12:3778.","journal-title":"Nat Commun"},{"key":"1872_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00858-z","volume":"13","author":"S Wu","year":"2025","unstructured":"Wu S, Guo D, Hu X, Yang M. The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. Biomark Res. 2025;13:141.","journal-title":"Biomark Res"},{"key":"1872_CR30","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/s41594-025-01663-w","volume":"32","author":"G Wei","year":"2025","unstructured":"Wei G, Coker H, Rodermund L, Almeida M, Roach HL, Nesterova TB, et al. M6A and the next complex direct xist RNA turnover and x-inactivation dynamics. Nat Struct Mol Biol. 2025;32:2242\u201351.","journal-title":"Nat Struct Mol Biol"},{"key":"1872_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li HB, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, et al. M6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548:338\u201342.","journal-title":"Nature"},{"key":"1872_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21594-6","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao Y, Yang Y, Guo W, Xu L, You M, Zhang YC, et al. METTL3-dependent m6A modification programs T follicular helper cell differentiation. Nat Commun. 2021;12:1333.","journal-title":"Nat Commun"},{"key":"1872_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.scib.2023.11.029","volume":"69","author":"W Guo","year":"2024","unstructured":"Guo W, Wang Z, Zhang Y, Li Y, Du Q, Zhang T, et al. Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells. Sci Bull (Beijing). 2024;69:82\u201396.","journal-title":"Sci Bull (Beijing)"},{"key":"1872_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong J, Cao G, Zhang T, Sefik E, Amezcua MC, Broughton JP, et al. M6A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28:253\u20136.","journal-title":"Cell Res"},{"key":"1872_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ajt.2025.01.017","volume":"25","author":"Y Liu","year":"2025","unstructured":"Liu Y, Fu Q, Yang M, Xu J, Zhou Z, Chen X, et al. Downregulation of N6-methyladenosine (m6A) methylation of Sema4D mRNA contributes to Treg dysfunction and allograft rejection. Am J Transpl. 2025;25:930\u201342.","journal-title":"Am J Transpl"},{"key":"1872_CR36","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1158\/0008-5472.CAN-25-0065","volume":"85","author":"C Huang","year":"2025","unstructured":"Huang C, Wang X, Gu Y, Ren K, Zang H, Zhang Y, et al. METTL14 enhances antitumor immunity through m6A-dependent loss of PD-1. Cancer Res. 2025;85:4151\u201363.","journal-title":"Cancer Res"},{"key":"1872_CR37","doi-asserted-by":"publisher","unstructured":"Jackson-Jones KA, Simons LM, Huang S, Joseph TL, Sawyer AM, Wu L, et al. Impact of N6-methyladenosine (m6A) machinery on HIV-1 replication in primary CD4+ T cells. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.11.07.686373.","DOI":"10.1101\/2025.11.07.686373"},{"key":"1872_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s10020-025-01295-2","volume":"31","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhang Y, Xie S, Liu K, Liu M, Li Y, et al. Reciprocal METTL3-PAX5 regulation in maintaining B-cell identity and promoting B-cell hyperreactivity in SLE. Mol Med. 2025;31:236.","journal-title":"Mol Med"},{"key":"1872_CR39","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.3390\/ijms24054721","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Li H, Lian Z, Deng S. The role of m(6)A modifications in B-cell development and B-cell-related diseases. Int J Mol Sci. 2023;24:4721.","journal-title":"Int J Mol Sci"},{"key":"1872_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29450-x","volume":"13","author":"J Rodr\u00edguez-Ubreva","year":"2022","unstructured":"Rodr\u00edguez-Ubreva J, Arutyunyan A, Bonder MJ, Pino-Molina JD, Clark SK, Calle-Fabregat CD, et al. Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses. Nat Commun. 2022;13:1779.","journal-title":"Nat Commun"},{"key":"1872_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103918","volume":"88","author":"Q Wu","year":"2025","unstructured":"Wu Q, Cai Y, Yan Z, Wang Y, Liu J, Guan X, et al. Redox-sensitive m6A regulation in atherosclerosis: METTL3 at the crossroads of mitochondrial quality control and pyroptosis. Redox Biol. 2025;88:103918.","journal-title":"Redox Biol"},{"key":"1872_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.25259\/Cytojournal_144_2024","volume":"22","author":"C Chen","year":"2025","unstructured":"Chen C, Huang H. Methyltransferase 3-mediated m6A modification of switch\/sucrose non-fermenting-related matrix-associated actin-dependent regulator of chromatin subfamily a member 5 promotes mycobacterium tuberculosis-infected macrophage M1 polarization and inflammation. Cytojournal. 2025;22:38.","journal-title":"Cytojournal"},{"key":"1872_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39614-y","volume":"14","author":"C Leoni","year":"2023","unstructured":"Leoni C, Bataclan M, Ito-Kureha T, Heissmeyer V, Monticelli S. The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells. Nat Commun. 2023;14:3862.","journal-title":"Nat Commun"},{"key":"1872_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25803-0","volume":"12","author":"H Song","year":"2021","unstructured":"Song H, Song J, Cheng M, Zheng M, Wang T, Tian S, et al. METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun. 2021;12:5522.","journal-title":"Nat Commun"},{"key":"1872_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106253","volume":"185","author":"Y Li","year":"2023","unstructured":"Li Y, Li J, Yu Q, Ji L, Peng B. METTL14 regulates microglia\/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis. Neurobiol Dis. 2023;185:106253.","journal-title":"Neurobiol Dis"},{"key":"1872_CR46","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1111\/febs.70030","volume":"292","author":"GD Campagnaro","year":"2025","unstructured":"Campagnaro GD, Kaysel Cruz A. Genetic and functional dissection of the glutamate-proline pathway reveals a shortcut for glutamate catabolism in Leishmania. FEBS J. 2025;292:2645\u201370.","journal-title":"FEBS J"},{"key":"1872_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.124110","volume":"385","author":"L Tan","year":"2026","unstructured":"Tan L, Lu T, Lu J, Chen X, Xiao F, Zhou L, et al. WTAP-m6A-ALOX15 axis mediates dendritic cells-keratinocytes interaction involved in lipid metabolism disorders to drive atopic dermatitis. Life Sci. 2026;385:124110.","journal-title":"Life Sci"},{"key":"1872_CR48","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41401-023-01207-2","volume":"45","author":"SJ Li","year":"2024","unstructured":"Li SJ, Wu YL, Chen JH, Shen SY, Duan J, Xu HE. Autoimmune diseases: targets, biology, and drug discovery. Acta Pharm Sin. 2024;45:674\u201385.","journal-title":"Acta Pharm Sin"},{"key":"1872_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70262","volume":"6","author":"X Song","year":"2025","unstructured":"Song X, Liang H, Nan F, Chen W, Li J, He L, et al. Autoimmune diseases: molecular pathogenesis and therapeutic targets. MedComm. 2025;6:e70262.","journal-title":"MedComm"},{"key":"1872_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116066","volume":"170","author":"Y Xu","year":"2024","unstructured":"Xu Y, Liu W, Ren L. Emerging roles and mechanism of m6A methylation in rheumatoid arthritis. Biomed Pharmacother. 2024;170:116066.","journal-title":"Biomed Pharmacother"},{"key":"1872_CR51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10863-024-10035-w","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu X, Xia Z, Liu L, Ren D. WTAP promotes fibroblast-like synoviocyte pyroptosis in rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3. J Bioenerg Biomembr. 2024;56:563\u201371.","journal-title":"J Bioenerg Biomembr"},{"key":"1872_CR52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3892\/etm.2024.12664","volume":"28","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Wan L. N6-methyladenosine methyltransferase METTL14 is associated with macrophage polarization in rheumatoid arthritis. Exp Ther Med. 2024;28:375.","journal-title":"Exp Ther Med"},{"key":"1872_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10753-026-02484-9","volume":"49","author":"S Li","year":"2026","unstructured":"Li S, Zhang M, Liang S, Wan L, Zhang X. METTL3-mediated m6A regulation of circINTS4\/miR-146b-3p axis in rheumatoid arthritis. Inflammation. 2026;49:107.","journal-title":"Inflammation"},{"key":"1872_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167112","volume":"1870","author":"T Miao","year":"2024","unstructured":"Miao T, Qiu Y, Chen J, Li P, Li H, Zhou W, et al. METTL3 knockdown suppresses RA-FLS activation through m6A-YTHDC2-mediated regulation of AMIGO2. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167112.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1872_CR55","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/art.42629","volume":"75","author":"J Tang","year":"2023","unstructured":"Tang J, Yu Z, Xia J, Jiang R, Chen S, Ye D, et al. METTL14-mediated m6A modification of TNFAIP3 involved in inflammation in patients with active rheumatoid arthritis. Arthritis Rheumatol. 2023;75:2116\u201329.","journal-title":"Arthritis Rheumatol"},{"key":"1872_CR56","doi-asserted-by":"publisher","first-page":"C1089","DOI":"10.1152\/ajpcell.00575.2022","volume":"324","author":"X Li","year":"2023","unstructured":"Li X, Xu X, Zhang Q, Ling M, Li X, Tan X. METTL14 promotes fibroblast-like synoviocytes activation via the LASP1\/SRC\/AKT axis in rheumatoid arthritis. Am J Physiol Cell Physiol. 2023;324:C1089\u2013100.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1872_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601259","volume":"16","author":"D Yan","year":"2025","unstructured":"Yan D, Wan L. WTAP modulates macrophage polarization in rheumatoid arthritis by targeting exosomal circ-CBLB via m6A modification. Front Immunol. 2025;16:1601259.","journal-title":"Front Immunol"},{"key":"1872_CR58","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.18632\/aging.204439","volume":"14","author":"L Wan","year":"2022","unstructured":"Wan L, Liu J, Huang C, Zhu Z, Li F, Sun G, et al. Role of m6A modification and novel circ_0066715\/miR-486-5p\/ETS1 axis in rheumatoid arthritis macrophage polarization progression. Aging (Albany NY). 2022;14:10009\u201326.","journal-title":"Aging (Albany NY)"},{"key":"1872_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70065","volume":"28","author":"X Cui","year":"2025","unstructured":"Cui X, Xu F, Pang X, Fan C, Jiang H. WTAP-mediated m6A modification of TRAIL-DR4 suppresses MH7A cell apoptosis. Int J Rheum Dis. 2025;28:e70065.","journal-title":"Int J Rheum Dis"},{"key":"1872_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10:102.","journal-title":"Signal Transduct Target Ther"},{"key":"1872_CR61","doi-asserted-by":"publisher","unstructured":"Ding QY, Zhou Y, Luo HW, Wei YZ, Feng YF, Zhang DM, et al. Triptolide derivative STP1 ameliorates murine systemic lupus erythematosus via targeting Fyn kinase. Acta Pharmacol Sin. 2026. https:\/\/doi.org\/10.1038\/s41401-026-01753-5.","DOI":"10.1038\/s41401-026-01753-5"},{"key":"1872_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-023-00643-4","volume":"29","author":"S Lu","year":"2023","unstructured":"Lu S, Wei X, Zhu H, Hu Z, Zheng M, Wu J, et al. M6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus. Mol Med. 2023;29:46.","journal-title":"Mol Med"},{"key":"1872_CR63","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.molcel.2021.07.037","volume":"81","author":"L Nair","year":"2021","unstructured":"Nair L, Zhang W, Laffleur B, Jha MK, Lim J, Lee H, et al. Mechanism of noncoding RNA-associated N6-methyladenosine recognition by an RNA processing complex during IgH DNA recombination. Mol Cell. 2021;81:3949\u201364.","journal-title":"Mol Cell"},{"key":"1872_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03735-y","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang X, Huang M, Luo A, Liu S, Cai M, et al. METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus. BMC Med. 2024;22:511.","journal-title":"BMC Med"},{"key":"1872_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1298","volume":"8","author":"Q Luo","year":"2020","unstructured":"Luo Q, Rao J, Zhang L, Fu B, Guo Y, Huang Z, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genom Med. 2020;8:e1298.","journal-title":"Mol Genet Genom Med"},{"key":"1872_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05790-4","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu Y, Lei L, Jiang L, Zeng H, Zhang Y, Fu C, et al. LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1\u03b1\/NF-\u03baB axis in psoriasis. Cell Death Dis. 2023;14:279.","journal-title":"Cell Death Dis"},{"key":"1872_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18085","volume":"28","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xiang Y, Miao X, Kuai L, Ding X, Ma T, et al. METTL14 promotes IL-6-induced viability, glycolysis and inflammation in HaCaT cells via the m6A modification of TRIM27. J Cell Mol Med. 2024;28:e18085.","journal-title":"J Cell Mol Med"},{"key":"1872_CR68","doi-asserted-by":"crossref","unstructured":"Ding T, Li B, Su R, Li X, Wang C. Pos1006 aberrant Th17 cells expansion and risk factors in ankylosing spondylitis patients complicated with cardiovascular events. Ann Rheum Dis. 2021;80:771.","DOI":"10.1136\/annrheumdis-2021-eular.3442"},{"key":"1872_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147989","volume":"894","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang C, Tang Q, Shi Y, Shen L. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO\/TNC in scleroderma. Gene. 2024;894:147989.","journal-title":"Gene"},{"key":"1872_CR70","unstructured":"Cai A, Rosek A, Khanna N, Webber A, Kozicki K, Khanna D, et al. Surveying RNA methylation in scleroderma highlights roles for demethylases ALKBH5 and FTO in fibrosis. Arthritis Rheumatol. 2025;77:suppl 9."},{"key":"1872_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg5234","volume":"9","author":"AM Maldonado L\u00f3pez","year":"2023","unstructured":"Maldonado L\u00f3pez AM, Ko EK, Huang S, Pacella G, Kuprasertkul N, D\u2019Souza CA, et al. Mettl3-catalyzed m(6)A regulates histone modifier and modification expression in self-renewing somatic tissue. Sci Adv. 2023;9:eadg5234.","journal-title":"Sci Adv"},{"key":"1872_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/tgh-24-140","volume":"10","author":"A Sohal","year":"2025","unstructured":"Sohal A, Nikzad N, Kowdley KV. Overlap syndromes in autoimmune liver disease: a review. Transl Gastroenterol Hepatol. 2025;10:33.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"1872_CR73","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/HEP.0000000000001374","volume":"83","author":"J Yao","year":"2026","unstructured":"Yao J, Liu P, Teng X, Kong D, Han B, Cui C, et al. Alcohol-induced disruption of hepatic m6A modification exacerbates alcohol-associated steatohepatitis by impairing liver immune microenvironment homeostasis. Hepatology. 2026;83:851\u201367.","journal-title":"Hepatology"},{"key":"1872_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202512799","volume":"13","author":"W Pan","year":"2026","unstructured":"Pan W, Yong Y, Li Y, Shi G, Zhang M, Wan L, et al. Hepatocyte Mettl3 deficiency drives primary sclerosing cholangitis and liver fibrosis via cholangiocyte-macrophage crosstalk. Adv Sci (Weinh). 2026;13:e12799.","journal-title":"Adv Sci (Weinh)"},{"key":"1872_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/ijms26010121","volume":"26","author":"D Aebisher","year":"2024","unstructured":"Aebisher D, Bartusik-Aebisher D, Przyg\u00f3rzewska A, Ole\u015b P, Wo\u017anicki P, Kawczyk-Krupka A. Key interleukins in inflammatory bowel disease-a review of recent studies. Int J Mol Sci. 2024;26:121.","journal-title":"Int J Mol Sci"},{"key":"1872_CR76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10565-024-09921-1","volume":"40","author":"X Xu","year":"2024","unstructured":"Xu X, Peng J, Wang N, Ocansey DKW, Zhang X, Mao F. HucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the METTL3-Slc37a2-YTHDF1 axis. Cell Biol Toxicol. 2024;40:74.","journal-title":"Cell Biol Toxicol"},{"key":"1872_CR77","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1007\/s11427-024-2799-6","volume":"68","author":"T Gong","year":"2025","unstructured":"Gong T, Zeng Z, Huang Z, Luo Y, Cao X, Li H, et al. Downregulation of METTL3 enhances TRADD-mediated apoptosis in inflammatory bowel disease. Sci China Life Sci. 2025;68:2010\u201327.","journal-title":"Sci China Life Sci"},{"key":"1872_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae060","volume":"17","author":"CB Ding","year":"2025","unstructured":"Ding CB, Yang X, Liu H, Roulis M, Chen H, Chen Y, et al. METTL3 modulates colonic epithelium integrity via maintaining the self-renewal and differentiation of Lgr5+ stem cell. J Mol Cell Biol. 2025;17:mjae060.","journal-title":"J Mol Cell Biol"},{"key":"1872_CR79","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41423-024-01156-8","volume":"21","author":"H Yin","year":"2024","unstructured":"Yin H, Ju Z, Zhang X, Zuo W, Yang Y, Zheng M, et al. Inhibition of METTL3 in macrophages provides protection against intestinal inflammation. Cell Mol Immunol. 2024;21:589\u2013603.","journal-title":"Cell Mol Immunol"},{"key":"1872_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/cei\/uxae025","volume":"217","author":"M Fang","year":"2024","unstructured":"Fang M, Yao J, Zhang H, Sun J, Yin Y, Shi H, et al. Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice. Clin Exp Immunol. 2024;217:57\u201377.","journal-title":"Clin Exp Immunol"},{"key":"1872_CR81","doi-asserted-by":"crossref","unstructured":"Truffinet F, Arco-Hierves A, Shalabi H, Pascaud J, Mazet P, Rivi\u00e8re E, et al. M6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sj\u00f6gren\u2019s disease. Ann Rheum Dis. 2024;ard:226224.","DOI":"10.1136\/ard-2024-226224"},{"key":"1872_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28645","volume":"10","author":"J Yin","year":"2024","unstructured":"Yin J, Fu J, Xu J, Chen C, Zhu H, Wang B, et al. Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sj\u00f6gren\u2019s syndrome. Heliyon. 2024;10:e28645.","journal-title":"Heliyon"},{"key":"1872_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.949206","volume":"13","author":"L Cheng","year":"2022","unstructured":"Cheng L, Li H, Zhan H, Liu Y, Li X, Huang Y, et al. Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sj\u00f6gren\u2019s syndrome. Front Immunol. 2022;13:949206.","journal-title":"Front Immunol"},{"key":"1872_CR84","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s11427-022-2323-4","volume":"66","author":"C Wang","year":"2023","unstructured":"Wang C, Chen C, Sun H, Mao K, Yao J, Zhang W, et al. M6A mRNA modification potentiates Th17 functions to inflame autoimmunity. Sci China Life Sci. 2023;66:2543\u201352.","journal-title":"Sci China Life Sci"},{"key":"1872_CR85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00018-025-06028-6","volume":"83","author":"X Pei","year":"2026","unstructured":"Pei X, Wang X, Ding J, Yu H, Xue C, Xie C, et al. B cell-specific METTL3 depletion exacerbates experimental autoimmune encephalomyelitis. Cell Mol Life Sci. 2026;83:63.","journal-title":"Cell Mol Life Sci"},{"key":"1872_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.31083\/j.fbl2811306","volume":"28","author":"Y Li","year":"2023","unstructured":"Li Y, Wang S, Liu Y, Zhang Y. Serum pentaxin 3 (PTX3) promotes NLRP3 inflammasome and pyroptosis in patients with up-regulated myasthenia gravis. Front Biosci (Landmark Ed). 2023;28:306.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1872_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03947-5","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Liu H, Ruan Z, Guo R, Sun C, Tang Y, et al. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. J Transl Med. 2023;21:166.","journal-title":"J Transl Med"},{"key":"1872_CR88","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41556-024-01368-0","volume":"26","author":"DF Jesus","year":"2024","unstructured":"Jesus DF, Zhang Z, Brown ZK, Li X, Xiao L, Hu J, et al. Redox regulation of m6A methyltransferase METTL3 in \u03b2-cells controls the innate immune response in type 1 diabetes. Nat Cell Biol. 2024;26:421\u201337.","journal-title":"Nat Cell Biol"},{"key":"1872_CR89","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1038\/s44318-024-00213-2","volume":"43","author":"S Kahraman","year":"2024","unstructured":"Kahraman S, Jesus DF, Wei J, Brown NK, Zou Z, Hu J, et al. M6A mRNA methylation by METTL14 regulates early pancreatic cell differentiation. EMBO J. 2024;43:5445\u201368.","journal-title":"EMBO J."},{"key":"1872_CR90","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00125-023-05900-z","volume":"66","author":"X Li","year":"2023","unstructured":"Li X, Yang Y, Li Z, Wang Y, Qiao J, Chen Z. Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice. Diabetologia. 2023;66:1084\u201396.","journal-title":"Diabetologia"},{"key":"1872_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1501061","volume":"15","author":"MF Bonfim","year":"2024","unstructured":"Bonfim MF, Aitchedji C, Van Goethem F, Sauvage L, Poinsot T, Calonne E, et al. The N6-methyladenosine RNA epigenetic modification modulates the amplification of coxsackievirus B1 in human pancreatic beta cells. Front Microbiol. 2024;15:1501061.","journal-title":"Front Microbiol"},{"key":"1872_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106933","volume":"196","author":"K Mo","year":"2023","unstructured":"Mo K, Chu Y, Liu Y, Zheng G, Song K, Song Q, et al. Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease. Pharmacol Res. 2023;196:106933.","journal-title":"Pharmacol Res."},{"key":"1872_CR93","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2024.2433628","volume":"58","author":"LN Li","year":"2025","unstructured":"Li LN, Wu JM, Zheng ZJ, Li SX, Cai MY, Zou MC. N6-methyladenosine modification of THBS1 induced by affluent WTAP promotes Graves\u2019 ophthalmopathy progression through glycolysis to affect Th17\/Treg balance. Autoimmunity. 2025;58:2433628.","journal-title":"Autoimmunity"},{"key":"1872_CR94","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/cells14171388","volume":"14","author":"AG Vasilopoulou","year":"2025","unstructured":"Vasilopoulou AG, Kalafati G, Drakopoulou E, Anagnou NPM. m6A mRNA methylation in hematopoiesis: the importance of writing, erasing, and reading. Cells. 2025;14:1388.","journal-title":"Cells"},{"key":"1872_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.gendis.2023.02.013","volume":"11","author":"Y Shan","year":"2024","unstructured":"Shan Y, Chen W, Li Y. The role of m6A RNA methylation in autoimmune diseases: novel therapeutic opportunities. Genes Dis. 2024;11:252\u201367.","journal-title":"Genes Dis"},{"key":"1872_CR96","doi-asserted-by":"publisher","DOI":"10.1242\/dev.204226","volume":"152","author":"X Hu","year":"2025","unstructured":"Hu X, He Y, Li S, Jiang Y, Yu R, Wu Y, et al. Acute inflammation induces acute megakaryopoiesis with impaired platelet production during fetal hematopoiesis. Development. 2025;152:dev204226.","journal-title":"Development"},{"key":"1872_CR97","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201548R","volume":"37","author":"L Zhao","year":"2023","unstructured":"Zhao L, Liu Y, Ma B, Liu X, Wei R, Nian H. METTL3 inhibits autoreactive Th17 cell responses in experimental autoimmune uveitis via stabilizing ASH1L mRNA. FASEB J. 2023;37:e22803.","journal-title":"FASEB J"},{"key":"1872_CR98","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300893R","volume":"37","author":"Y Wei","year":"2023","unstructured":"Wei Y, Yang C, Liu Y, Sun D, Li X, Wei R, et al. Mettl3 induced miR-338-3p expression in dendritic cells promotes antigen-specific Th17 cell response via regulation of Dusp16. FASEB J. 2023;37:e23277.","journal-title":"FASEB J"},{"key":"1872_CR99","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s12276-024-01159-5","volume":"56","author":"HR Jung","year":"2024","unstructured":"Jung HR, Lee J, Hong SP, Shin N, Cho A, Shin DJ, et al. Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Exp Mol Med. 2024;56:355\u201369.","journal-title":"Exp Mol Med"},{"key":"1872_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1359","volume":"13","author":"WJ Ni","year":"2023","unstructured":"Ni WJ, Zhou H, Lu H, Ma NN, Hou BB, Li W, et al. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Clin Transl Med. 2023;13:e1359.","journal-title":"Clin Transl Med"},{"key":"1872_CR101","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1681\/ASN.0000000000000428","volume":"35","author":"YC Tsai","year":"2024","unstructured":"Tsai YC, Hsieh TH, Liao YR, Tsai MT, Lin TP, Lee DY, et al. METTL3-mediated N6-methyladenosine mRNA modification and cGAS-STING pathway activity in kidney fibrosis. J Am Soc Nephrol. 2024;35:1312\u201329.","journal-title":"J Am Soc Nephrol"},{"key":"1872_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1739011","volume":"17","author":"M Xu","year":"2026","unstructured":"Xu M, Chen R, Zeng X, Pan M, Wang C, Qi Y, et al. METTL3-driven m6A modification of NLRC5 promotes renal fibrosis in chronic kidney disease through Keap1\/Nrf2\/ARE signaling pathway. Front Immunol. 2026;17:1739011.","journal-title":"Front Immunol"},{"key":"1872_CR103","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10238-024-01346-8","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Sun N, He R, Wang Z, Jin J, Gao T, et al. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy. Clin Exp Med. 2024;24:92.","journal-title":"Clin Exp Med"},{"key":"1872_CR104","doi-asserted-by":"publisher","first-page":"gfae069","DOI":"10.1093\/ndt\/gfae069.1242","volume":"39","author":"C Tang","year":"2024","unstructured":"Tang C, Liu Y, Wang X, Huang M, Luo A, Liu S, et al. Aberrant m6A modification pattern and m6A-related proteins expression in SLE. Nephrol Dial Transpl. 2024;39:gfae069\u20131242.","journal-title":"Nephrol Dial Transpl"},{"key":"1872_CR105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12882-024-03549-3","volume":"25","author":"D Li","year":"2024","unstructured":"Li D, Li Y, Zhu K, Yuan Y, He Z, Sun Q, et al. Analysis of m6A-regulated genes and subtype classification in lupus nephritis. BMC Nephrol. 2024;25:119.","journal-title":"BMC Nephrol"},{"key":"1872_CR106","doi-asserted-by":"publisher","unstructured":"Xia X, Long C, Chen W, Yao X, Xu B, Teng H, et al. METTL3-targeted intervention on nuclear factors RORA\/ROR\u03b3t suppressing pathogenic T helper 17 cell differentiation and restores kidney damage in lupus nephritis. Kidney Int. 2026. https:\/\/doi.org\/10.1016\/j.kint.2026.01.025.","DOI":"10.1016\/j.kint.2026.01.025"},{"key":"1872_CR107","doi-asserted-by":"publisher","unstructured":"Esteva-Socias M, Bhattarai DP, Achour C, Baidya P, Fontanari G, Seier K, et al. METTL3 regulates exocytosis independently of m6A. 2025. https:\/\/doi.org\/10.1101\/2025.05.26.656168.","DOI":"10.1101\/2025.05.26.656168"},{"key":"1872_CR108","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.imlet.2023.04.008","volume":"258","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yuan Y, Zhou Z, Jiang X, He S, Wei F, et al. Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway. Immunol Lett. 2023;258:35\u201344.","journal-title":"Immunol Lett"},{"key":"1872_CR109","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12016-025-09041-6","volume":"68","author":"L Xu","year":"2025","unstructured":"Xu L, Shen T, Li Y, Wu X. The role of m6A modification in autoimmunity: emerging mechanisms and therapeutic implications. Clin Rev Allergy Immunol. 2025;68:29.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1872_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30209-7","volume":"13","author":"Z Luo","year":"2022","unstructured":"Luo Z, Zhang J, Fei J, Ke S. Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences. Nat Commun. 2022;13:2720.","journal-title":"Nat Commun"},{"key":"1872_CR111","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ymthe.2024.12.003","volume":"33","author":"KM Pilala","year":"2025","unstructured":"Pilala KM, Panoutsopoulou K, Papadimitriou MA, Soureas K, Scorilas A, Avgeris M. Exploring the methyl-verse: dynamic interplay of epigenome and m6A epitranscriptome. Mol Ther. 2025;33:447\u201364.","journal-title":"Mol Ther"},{"key":"1872_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103513","volume":"28","author":"H Li","year":"2023","unstructured":"Li H, Zhang Q, Feng Q, You Q, Guo X. The development of small molecules targeting methyltransferase-like 3. Drug Discov Today. 2023;28:103513.","journal-title":"Drug Discov Today"},{"key":"1872_CR113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, Braekeleer ED, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"1872_CR114","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/0006-2952(78)90018-7","volume":"27","author":"RW Fuller","year":"1978","unstructured":"Fuller RW, Nagarajan R. Inhibition of methyltransferases by some new analogs of S-adenosylhomocysteine. Biochem Pharm. 1978;27:1981\u20133.","journal-title":"Biochem Pharm"},{"key":"1872_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk2709","volume":"14","author":"JN Wang","year":"2022","unstructured":"Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, et al. Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Sci Transl Med. 2022;14:eabk2709.","journal-title":"Sci Transl Med"},{"key":"1872_CR116","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21037\/tcr-2025-aw-2392","volume":"15","author":"T Lin","year":"2026","unstructured":"Lin T, Chen X, Huang H, Zhang J, Xu Y, Lin J. Pre-clinical anti-tumor activity and preliminary safety of METTL3 inhibitors STM2457 and UZH1a in neuroblastoma. Transl Cancer Res. 2026;15:186.","journal-title":"Transl Cancer Res"},{"key":"1872_CR117","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1021\/acs.jmedchem.1c00773","volume":"64","author":"A Dolbois","year":"2021","unstructured":"Dolbois A, Bedi RK, Bochenkova E, M\u00fcller A, Moroz-Omori EV, Huang D, et al. 1,4,9-triazaspiro[5.5]undecan-2-one derivatives as potent and selective METTL3 inhibitors. J Med Chem. 2021;64:12738\u201360.","journal-title":"J Med Chem"},{"key":"1872_CR118","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","volume":"13","author":"AA Guirguis","year":"2023","unstructured":"Guirguis AA, Ofir-Rosenfeld Y, Knezevic K, Blackaby W, Hardick D, Chan YC, et al. Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity. Cancer Discov. 2023;13:2228\u201347.","journal-title":"Cancer Discov"},{"key":"1872_CR119","doi-asserted-by":"publisher","unstructured":"Salkeni MA, Papadopoulos KP, Hornstein NJ, Tsai F, Snyder M, McMahon C, et al. 587 Phase 1b\/2 dose escalation and expansion study of STC-15, a METTL3 inhibitor, in combination with toripalimab, an anti-PD-1 antibody, in patients with advanced solid tumors. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-SITC2025.0587.","DOI":"10.1136\/jitc-2025-SITC2025.0587"},{"key":"1872_CR120","doi-asserted-by":"publisher","unstructured":"Fischl H, Samuels TJ, Andrews B, Vasiliauskait\u0117 L, Jupp D, Saunders CJ, et al. Inhibition of METTL3 by STC-15 induces RNA misprocessing that results in dsRNA formation and activates innate immunity. bioRxiv. 2025 https:\/\/doi.org\/10.64898\/2025.12.05.692335.","DOI":"10.64898\/2025.12.05.692335"},{"key":"1872_CR121","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1021\/acs.jmedchem.4c02225","volume":"68","author":"G Dutheuil","year":"2025","unstructured":"Dutheuil G, Oukoloff K, Korac J, Lenoir F, Bousmaqui ME, Probst N, et al. Discovery, optimization, and preclinical pharmacology of EP652, a METTL3 inhibitor with efficacy in liquid and solid tumor models. J Med Chem. 2025;68:2981\u20133003.","journal-title":"J Med Chem"},{"key":"1872_CR122","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acsmedchemlett.4c00216","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, He Y, Kang Y, Shen L, Zhang W, Yan Y, et al. Virtual screening and molecular docking: discovering novel METTL3 inhibitors. ACS Med Chem Lett. 2024;15:1491\u20139.","journal-title":"ACS Med Chem Lett"},{"key":"1872_CR123","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2023-189993","volume":"142","author":"G Fraser","year":"2023","unstructured":"Fraser G, Sorlet C, Parmentier N, Hartiel AF, Hospied S, Mompied C, et al. EP102: pharmacological inhibition of METTL3 elicits tumor growth inhibition in vivo and demonstrates synergy with venetoclax in various AML models. Blood. 2023;142:2263.","journal-title":"Blood"},{"key":"1872_CR124","first-page":"783","volume":"83","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kim S, Jin MS, Kim YC. Discovery of substituted indole derivatives as allosteric inhibitors of m6A-RNA methyltransferase, METTL3-14 complex. Drug Dev Res. 2022;83:783\u201399.","journal-title":"Drug Dev Res"},{"key":"1872_CR125","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1021\/acs.jmedchem.2c01601","volume":"66","author":"F Fiorentino","year":"2023","unstructured":"Fiorentino F, Menna M, Rotili D, Valente S, Mai A. METTL3 from target validation to the first small-molecule inhibitors: a medicinal chemistry journey. J Med Chem. 2023;66:1654\u201377.","journal-title":"J Med Chem"},{"key":"1872_CR126","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ph15040440","volume":"15","author":"JH Lee","year":"2022","unstructured":"Lee JH, Choi N, Kim S, Jin MS, Shen H, Kim YC. Eltrombopag as an allosteric inhibitor of the METTL3-14 complex affecting the m6A methylation of RNA in acute myeloid leukemia cells. Pharmaceuticals (Basel). 2022;15:440.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1872_CR127","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1080\/07391102.2023.2291162","volume":"43","author":"M Ganguly","year":"2025","unstructured":"Ganguly M, Gupta R, Roychowdhury A, Hazra D. De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for acute myeloid leukaemia. J Biomol Struct Dyn. 2025;43:1038\u201351.","journal-title":"J Biomol Struct Dyn"},{"key":"1872_CR128","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00044-025-03464-8","volume":"34","author":"AR Smith","year":"2025","unstructured":"Smith AR, Nar R, Li Y, Gour A, Sharma A, Qian Z, et al. Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex. Med Chem Res. 2025;34:2299\u2013308.","journal-title":"Med Chem Res"},{"key":"1872_CR129","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","volume":"31","author":"W Du","year":"2024","unstructured":"Du W, Huang Y, Chen X, Deng Y, Sun Y, Yang H, et al. Discovery of a PROTAC degrader for METTL3-METTL14 complex. Cell Chem Biol. 2024;31:177\u201383.","journal-title":"Cell Chem Biol"},{"key":"1872_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116843","volume":"279","author":"K Hwang","year":"2024","unstructured":"Hwang K, Bae J, Jhe YL, Kim J, Cheong JH, Choi HS, et al. Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancer. Eur J Med Chem. 2024;279:116843.","journal-title":"Eur J Med Chem"},{"key":"1872_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.878135","volume":"13","author":"Y Du","year":"2022","unstructured":"Du Y, Yuan Y, Xu L, Zhao F, Wang W, Xu Y, et al. Discovery of METTL3 small molecule inhibitors by virtual screening of natural products. Front Pharmacol. 2022;13:878135.","journal-title":"Front Pharm"},{"key":"1872_CR132","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yjmcc.2025.04.006","volume":"203","author":"L Li","year":"2025","unstructured":"Li L, Chai Q, Guo C, Wei J, Qin Y, Liu H, et al. METTL3-mediated N6-methyladenosine modification contributes to vascular calcification. J Mol Cell Cardiol. 2025;203:22\u201334.","journal-title":"J Mol Cell Cardiol"},{"key":"1872_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156551","volume":"139","author":"Y Xia","year":"2025","unstructured":"Xia Y, Wang Y, Chen K, Zhang M, Jiang Q, Xu T. Quercetin attenuated necroptosis and apoptosis caused by LPS-induced mitochondrial function dysfunction through the METTL3-mediated PTEN m6A methylation\/PI3K\/AKT signaling in broiler livers. Phytomedicine. 2025;139:156551.","journal-title":"Phytomedicine"},{"key":"1872_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308786","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou X, Yang X, Huang S, Lin G, Lei K, Wang Q, et al. Inhibition of METTL3 alleviates NLRP3 inflammasome activation via increasing ubiquitination of NEK7. Adv Sci (Weinh). 2024;11:e2308786.","journal-title":"Adv Sci (Weinh)"},{"key":"1872_CR135","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.3390\/molecules30122634","volume":"30","author":"CR Alvizo-Rodr\u00edguez","year":"2025","unstructured":"Alvizo-Rodr\u00edguez CR, Calzada F, L\u00f3pez-V\u00e1zquez U, Tiburcio FT, Hernandez-Rivera JA, Carrasco-Carballo A, et al. Alteration of m6A methylation in breast cancer cells by Kalanchoe pinnata aqueous extract. Molecules. 2025;30:2634.","journal-title":"Molecules"},{"key":"1872_CR136","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1182\/blood-2024-206594","volume":"144","author":"C Jiao","year":"2024","unstructured":"Jiao C, Hu C, Wu C, Zhou J, Liu Q, Ge J. The TCM monomer isoliquiritigenin targeting METTL3, shows potential anti-leukemia activity. Blood. 2024;144:7466.","journal-title":"Blood"},{"key":"1872_CR137","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","volume":"26","author":"S Selberg","year":"2019","unstructured":"Selberg S, Blokhina D, Aatonen M, Koivisto P, Siltanen A, Mervaala E, et al. Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site. Cell Rep. 2019;26:3762\u20133771.","journal-title":"Cell Rep"},{"key":"1872_CR138","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s42003-025-08623-6","volume":"8","author":"A Liu","year":"2025","unstructured":"Liu A, Huo Z, Xu Z, Liu S, Jiao Y, Li R, et al. Transcriptome-wide regulation of folate on neural mRNA m6A methylome via carbon metabolism in Drosophila and mammals. Commun Biol. 2025;8:1151.","journal-title":"Commun Biol"},{"key":"1872_CR139","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.3390\/ijms26115233","volume":"26","author":"Y Jin","year":"2025","unstructured":"Jin Y, Song J, Diao Z, Han X, Fan Z. Betaine alleviates bisphosphonate-related osteonecrosis of the jaw by rescuing BMSCs function in an m6A-METTL3-dependent manner. Int J Mol Sci. 2025;26:5233.","journal-title":"Int J Mol Sci"},{"key":"1872_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10565-024-09975-1","volume":"41","author":"X Ji","year":"2025","unstructured":"Ji X, Huang Z, Zhou C, Wang Y, Geng D, Zhang G, et al. Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway. Cell Biol Toxicol. 2025;41:38.","journal-title":"Cell Biol Toxicol"},{"key":"1872_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125185","volume":"242","author":"LB Truong","year":"2023","unstructured":"Truong LB, Medina-Cruz D, Mostafavi E. Current state of RNA delivery using lipid nanoparticles to extrahepatic tissues: a review towards clinical translation. Int J Biol Macromol. 2023;242:125185.","journal-title":"Int J Biol Macromol"},{"key":"1872_CR142","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/j.gastro.2021.12.269","volume":"162","author":"S Wang","year":"2022","unstructured":"Wang S, Gao S, Zeng Y, Zhu L, Mo Y, Wong CC, et al. N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer. Gastroenterology. 2022;162:1183\u201396.","journal-title":"Gastroenterology"},{"key":"1872_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112259","volume":"42","author":"S Luo","year":"2023","unstructured":"Luo S, Liao C, Zhang L, Ling C, Zhang X, Xie P, et al. METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling. Cell Rep. 2023;42:112259.","journal-title":"Cell Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01872-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:53Z","timestamp":1789635833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01872-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01872-z","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}